Featured Articles

  1. Expand Capacity In Buffer Management 2/1/2018

    Biomanufacturing requires large volumes of buffers, and preparation of these liquids can quickly become a bottleneck. Here, two options that can help intensify your large-scale buffer management are presented.

  2. How Biogen Integrated PAT With End-To-End Supply Chain Transparency

    To drive dependable critical process control requirements, Biogen explored novel strategies to increase process and raw material control and optimize communication of data throughout the supply chain.

  3. Add mRNA Capacity — Flexibly

    Learn about a platform that addresses five critical pain points to help mRNA manufacturers flexibly scale while improving the digital maturity of their sites.

  4. Research And Industry Join Forces As Modalities Merge

    How is current research driving the convergence of therapeutic modalities, and what implications does this have for patients and healthcare? Read on to find answers to these questions and more.

  5. Standardization And Flexibility In Aseptic Filling

    Standardization and flexibility in aseptic filling were thought to be mutually exclusive. But what if there was a standardized system with flexibility built into the aseptic process, so you didn’t have to choose?

  6. Unexpected SEC Results – Can It Be Improved?

    Sometimes, your size exclusion chromatography (SEC) results don’t look the way you want them to. Learn how to fix issues like poor resolution, peak tailing, and fronting from the tips shared in this FAQ.

  7. Designing Agile Manufacturing With An Integrated Drug Product Ecosystem

    Companies aiming to accelerate biomanufacturing operations and use resources efficiently need access to technologies that can safely and efficiently complete their workflow from discovery to delivery.

  8. Staying Flexible In Biomanufacturing

    The concept of optionality is key to staying flexible in biomanufacturing by keeping your options open and having multiple pathways to take while navigating through this highly uncertain environment. 

  9. Oligonucleotide Manufacturing: Take Control Of Your Process

    What do you need to know before you take your process in-house? A team of experts on nucleic acids therapeutics outlined five key things for you to consider as you make the change.